AIN HOLDINGS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,948 JPY | +0.93% |
|
+1.00% | +32.95% |
| Sales 2024 * | 396B 2.5B 209B | Sales 2025 * | 421B 2.66B 222B | Capitalization | 208B 1.32B 110B |
|---|---|---|---|---|---|
| Net income 2024 * | 10.46B 66.03M 5.51B | Net income 2025 * | 10.51B 66.34M 5.53B | EV / Sales 2024 * | 0.41 x |
| Net cash position 2024 * | 46.9B 296M 24.7B | Net cash position 2025 * | 55.1B 348M 29.01B | EV / Sales 2025 * | 0.36 x |
| P/E ratio 2024 * |
20
x | P/E ratio 2025 * |
19.9
x | Employees | 10,561 |
| Yield 2024 * |
1.03% | Yield 2025 * |
1.09% | Free-Float | 76.47% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +0.93% | ||
| 1 week | +1.00% | ||
| Current month | +7.64% | ||
| 1 month | +8.96% | ||
| 3 months | +27.39% | ||
| 6 months | +42.23% | ||
| Current year | +32.95% |
1 week
5 840.00
6 119.00
1 month
5 425.006 119.00
Current year
4 353.006 119.00
1 year
4 023.006 119.00
3 years
4 023.008 350.00
5 years
4 023.009 160.00
10 years
2 195.009 330.00
| Managers | Title | Age | Since |
|---|---|---|---|
Hideki Fujiwara
DFI | Director of Finance/CFO | - | - |
Kiichi Otani
PSD | President | 72 | 01/80/01 |
Takanobu Murase
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Junro Ito
BRD | Director/Board Member | 65 | 01/19/01 |
Kiichi Otani
PSD | President | 72 | 01/80/01 |
| Director/Board Member | 64 | 01/86/01 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.66% | 10 M€ | +8.27% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 5,948 | -0.08% | 356,900 |
| 25/24/25 | 5,953 | -1.03% | 574,000 |
| 24/24/24 | 6,015 | +0.92% | 274,100 |
| 23/24/23 | 5,960 | +0.59% | 164,000 |
| 22/24/22 | 5,925 | +0.61% | 231,600 |
Delayed Quote Japan Exchange, April 26, 2024 at 11:30 am IST
More quotes
Ain Holdings Inc, is a Japan-based company engaged in the operation of pharmacies and retail business. The Company has three business segments. The Pharmacy segment operates and franchises pharmacies, and provides consulting services related to opening pharmacies. Through its subsidiaries, this segment is also involved in the provision of consultation services for medical-related affairs and manpower dispatching of doctors and pharmacists, as well as the sale of generic drugs. The Retail segment operates cosmetics business and drugstores. The Others segment is engaged in the leasing of buildings and the sales of cosmetics.
Sector
Drug Retailers
Calendar
04/06/2024
- Q4 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
5,948
JPY
Average target price
5,370
JPY
Spread / Average Target
-9.72%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +32.95% | 1.32B | |
| -12.86% | 8.57B | |
| +6.76% | 419M | |
| +5.93% | 282M | |
| +10.56% | 224M | |
| -8.26% | 85.07M | |
| -46.83% | 81.99M | |
| +20.94% | 59.57M |
- Stock Market
- Equities
- 9627 Stock
